London Stock Exchange Notice Suspension - MGC Pharmaceuticals Limited
03 April 2024 - 8:30AM
RNS Regulatory News
RNS Number : 0236J
London Stock Exchange Notice
03 April 2024
NOTICE
03/04/2024 7:30am
TEMPORARY SUSPENSION OF TRADING ON MAIN MARKET - STANDARD
SEGMENT
MGC PHARMACEUTICALS
LIMITED
At the request of the company,
trading on Main Market - Standard Segment for the under-mentioned security has been temporarily
suspended from 03/04/2024 7:30am.
ORDINARY SHARES OF NO PAR VALUE,
FULLY PAID (DI)
(BK70NQ9)
(AU000000MXC6)
If you have any queries relating to
the above, please contact the company's broker on +44
203 179 5300.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
EXCDZGGDDZGGDZM
Mgc Pharmaceuticals (LSE:MXC)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
Mgc Pharmaceuticals (LSE:MXC)
Historical Stock Chart
Von Dez 2023 bis Dez 2024